Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Bazargan

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Journal (Sudbury, Mass.)|July 26, 2022
Current State of Cell Therapies for Genitourinary MalignanciesMohammed A Alkhouli, Sarah Bazargan, Shari Pilon-Thomas, et al.
ACS Nano|January 28, 2017
Computational Sensing Using Low-Cost and Mobile Plasmonic Readers Designed by Machine LearningZachary S Ballard, Daniel Shir, Aashish Bhardwaj, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
Histology-guided mathematical model of tumor oxygenation: sensitivity analysis of physical and computational parametersAwino Maureiq E Ojwang', Sarah Bazargan, Joseph O Johnson, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
A virtual cohort framework with applications to adoptive cell therapy in bladder cancerHannah G Anderson, Sarah Bazargan, David J Nusbaum, et al.
Lab on a Chip|April 1, 2020
Contact lens-based lysozyme detection in tear using a mobile sensorZachary Ballard, Sarah Bazargan, Diane Jung, et al.
Journal for Immunotherapy of Cancer|January 6, 2022
TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8<sup>+</sup> T cell and XCR1<sup>+</sup> dendritic cell spatial co-localizationAlycia Gardner, Álvaro de Mingo Pulido, Kay Hänggi, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
PETIL: Predicting Expansion of Tumor Infiltrating Lymphocytes for the Adoptive Cell Immunotherapy in Bladder CancersKayode D Olumoyin, Ahmet Murat Aydin, Sarah Bazargan, et al.
Frontiers in Immunology|October 30, 2023
Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancerSarah Bazargan, Brittany Bunch, Awino Maureiq E Ojwang', et al.
Frontiers in Immunology|March 30, 2026
Transdermal bicarbonate buffer therapy increases intratumoral pH and elicits antitumor responses in bladder cancerOluwaseyi Oluwatola, Sarah Bazargan, Pietro Irrera, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Journal (Sudbury, Mass.)|July 26, 2022
Current State of Cell Therapies for Genitourinary MalignanciesMohammed A Alkhouli, Sarah Bazargan, Shari Pilon-Thomas, et al.
ACS Nano|January 28, 2017
Computational Sensing Using Low-Cost and Mobile Plasmonic Readers Designed by Machine LearningZachary S Ballard, Daniel Shir, Aashish Bhardwaj, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
Histology-guided mathematical model of tumor oxygenation: sensitivity analysis of physical and computational parametersAwino Maureiq E Ojwang', Sarah Bazargan, Joseph O Johnson, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
A virtual cohort framework with applications to adoptive cell therapy in bladder cancerHannah G Anderson, Sarah Bazargan, David J Nusbaum, et al.
Lab on a Chip|April 1, 2020
Contact lens-based lysozyme detection in tear using a mobile sensorZachary Ballard, Sarah Bazargan, Diane Jung, et al.
Journal for Immunotherapy of Cancer|January 6, 2022
TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8<sup>+</sup> T cell and XCR1<sup>+</sup> dendritic cell spatial co-localizationAlycia Gardner, Álvaro de Mingo Pulido, Kay Hänggi, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
PETIL: Predicting Expansion of Tumor Infiltrating Lymphocytes for the Adoptive Cell Immunotherapy in Bladder CancersKayode D Olumoyin, Ahmet Murat Aydin, Sarah Bazargan, et al.
Frontiers in Immunology|October 30, 2023
Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancerSarah Bazargan, Brittany Bunch, Awino Maureiq E Ojwang', et al.
Frontiers in Immunology|March 30, 2026
Transdermal bicarbonate buffer therapy increases intratumoral pH and elicits antitumor responses in bladder cancerOluwaseyi Oluwatola, Sarah Bazargan, Pietro Irrera, et al.
Pageof 1